Rehabilitation effect of oral drug on the patients with proliferative diabetic retinopathy after operation

by Wei Zu, Zhi-Kun Xin
Published 2014-08-01

Efficacy of Epalrestat, Duloxetine and Epalrestat in Combination with Methylcobalamine in Diabetic Peripheral Neuropathy

by Abhilash Penchala, Manasa Macharla, Subrahmanyam Bandaru Siva, Venkateshwarlu Eggadi, Goverdhan Puchchakayala, Nagesh Adla, Reddy Gade Amulya, Sharvana Bhava Bandaru Sheshagiri
Published 2016-12-01

Clinical observation on the curative effect of epalrestat combined with compound anisodine in treatment of non-proliferative diabetic retinopathy

by Xiu-Yun Gao, Hui-Yao Cai, Wen-Jian Shi, Jia-Xin Chen
Published 2019-06-01

Epalrestat improves motor symptoms by reducing oxidative stress and inflammation in the reserpine induced mouse model of Parkinson’s disease

by Md. Mahbubur Rahman, Rupali Rani Chakraborti, Md. Abdullah Potol, Ariful Haque Abir, Ozayra Sharmin, Mahabub Alam, Md. Fazlur Rahman Khan, Rownock Afrin, Humayra Jannat, Rasiqh Wadud, Zaki Farhad Habib
Published 2020-03-01

Evaluation of renal function and oxidative stress after adjuvant epalrestat treatment of early diabetic nephropathy

by Ge Zhao, Min-Xiu Yao
Published 2017-04-01

Assessment of the renal function, peroxidation damage and inflammatory injury after epalrestat combined with alprostadil treatment of early diabetic nephropathy

by Hai-Xia Li, Shu-Juan Liu
Published 2017-05-01

Alpha lipoic acid combined with epalrestat: a therapeutic option for patients with diabetic peripheral neuropathy

by Wang XT, Lin HX, Xu S, Jin YL, Zhang R
Published 2018-09-01

Aldo-keto reductase inhibitors increase the anticancer effects of tyrosine kinase inhibitors in chronic myelogenous leukemia

by Megumi Kikuya, Kenta Furuichi, Takuya Hirao, Satoshi Endo, Naoki Toyooka, Kousei Ito, Shigeki Aoki
Published 2021-09-01

Epalrestat increases intracellular glutathione levels in Schwann cells through transcription regulation

by Keisuke Sato, Kaori Yama, Yu Murao, Ryosuke Tatsunami, Yoshiko Tampo
Published 2014-01-01

Epalrestat increases glutathione, thioredoxin, and heme oxygenase-1 by stimulating Nrf2 pathway in endothelial cells

by Kaori Yama, Keisuke Sato, Natsuki Abe, Yu Murao, Ryosuke Tatsunami, Yoshiko Tampo
Published 2015-04-01

Repurposing the aldose reductase inhibitor and diabetic neuropathy drug epalrestat for the congenital disorder of glycosylation PMM2-CDG

by Sangeetha Iyer, Feba S. Sam, Nina DiPrimio, Graeme Preston, Jan Verheijen, Kausalya Murthy, Zachary Parton, Hillary Tsang, Jessica Lao, Eva Morava, Ethan O. Perlstein
Published 2019-11-01

Effect of Epalrestat combined with Huoxue Huayu preparation on early diabetic retinopathy and its effect on serum oxidative stress and inflammatory factors

by Ru Ouyang
Published 2021-02-01